August Troendle

August James Troendle is the founder of Medpace, Inc., founded in 1992, serving as Chairman, President & Chief Executive Officer.
Dr. Troendle is the founder of Medpace Holdings, Inc., founded in 1992, serving as Chairman, President & Chief Executive Officer.
Dr. Troendle was the founder of Symplmed Pharmaceuticals LLC, founded in 2013, serving as Director.
Dr. Troendle is the founder of LIB Therapeutics LLC, founded in 2015, serving as Chairman.
Current jobs include Chief Executive Officer at Medpace Medical Device, Inc.; Chairman at CinRx Pharma LLC since 2015; Managing Director at Medpace Germany GmbH since 2018; and Director at Medpace UK Ltd. since 2007.
Former jobs include Senior Associate Director at Sandoz, Inc. from 1987 to 1992; Director at Xenon Pharmaceuticals, Inc. from 2007 to 2008; Director at Coherus Oncology, Inc. from 2012 to 2018; Director at CinCor Pharma, Inc. from 2018 to 2021; President at Medpace Research, Inc.; and Medical Review Officer-Metabolic Division at The FDA Alliance from 1986 to 1987.
Education includes an MBA from Boston University and a doctorate from the University of Maryland School of Medicine.